Menchik Argues for Global, Equitable COVID-19 Vaccine Solution
“While the process of science and the products it yields are noble, science for outrageous profit that costs people their lives is not noble. That is why I can no longer in good conscience be part of Moderna’s trials.”
Najam in Bloomberg on Corporate America and Climate Change
Dean Adil Najam discusses how U.S. corporations have been taking action on controversial social and political issues such as climate change.